Aurobindo Pharma USA, Inc. Email Format

Pharmaceutical ManufacturingNew Jersey, United States1001-5000 Employees

Aurobindo Pharma USA, Inc. is a pharmaceutical manufacturing company based in East Windsor, New Jersey, with a workforce of approximately 1,000 to 5,000 employees. It provides a broad portfolio of generic pharmaceuticals to pharmacists and patients in the United States, consisting of more than 150 product families across multiple therapeutic categories, developed since its first US ANDA approval in 2004. The company has been recognized for growth, including being named the fastest growing pharmaceutical company in 2012 and, by early 2013, ranking among the top 10 pharmaceutical companies in terms of total prescriptions dispensed. In 2026, the company announced plans to acquire Lannett Company for $250 million, and later received FTC approval for the acquisition; it also expanded its North American footprint with facility expansions in Windsor, Canada, and Princeton, New Jersey, in 2025. Revenue is reported in the range of $250 million to $500 million.

Get verified Aurobindo Pharma USA, Inc. emails free

Company overview Employee directory